Related Experiment Video
Updated: Nov 7, 2025
09:04
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
Published on: March 28, 2025
507
Efficient immunogenic peptide antigen delivery to dendritic cells using an ESCRT-mediated extracellular vesicle
Sakika Kimura1, Koki Maeda1, Ryuichi Nagashima2
1Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University, Japan.
Vaccine
|April 30, 2021
Summary
Researchers developed novel extracellular vesicles to deliver antigens. These vesicles enable dendritic cells to present antigens on MHC class I, activating cytotoxic T lymphocytes (CTLs) for effective vaccines.
Area of Science:
- Immunology
- Cell Biology
- Vaccinology
Background:
- Cell-mediated adaptive immunity is crucial for eliminating virus-infected and tumor cells.
- Dendritic cells present antigens on MHC class I to activate cytotoxic T lymphocytes (CTLs).
- Exogenous antigens are typically presented on MHC class II, limiting CTL activation.
Purpose of the Study:
- To develop a method for exogenous antigen delivery that facilitates MHC class I presentation.
- To create a vaccine strategy that elicits cell-mediated adaptive immune responses.
Main Methods:
- Utilized extracellular vesicles (EVs) incorporating antigenic proteins.
- Employed the endosomal sorting complexes required for transport (ESCRT)-mediated vesicle formation pathway.
- Demonstrated EV delivery of contents to dendritic cell cytoplasm.
Main Results:
- Engineered EVs successfully incorporated antigenic proteins.
- EVs delivered antigens into the cytoplasm of dendritic cells.
- Activated antigen-specific CTLs.
Conclusions:
- Developed a novel EV-based technology for antigen delivery.
- This method facilitates MHC class I presentation and CTL activation.
- Potential application in developing new CTL-inducing peptide vaccines.
